Biolife Sciences (BLFE) Financial Statements
Biolife Sciences Financial Overview
Biolife Sciences's market cap is currently $4.83K. The company's EPS TTM is $-0.01; its P/E ratio is -0.00; Biolife Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Nov 20 | Nov 19 | Nov 18 | Nov 17 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 411.69K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -985.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.24M | $ 0.00 | $ -42.28K | $ -329.00K |
| EBITDA | $ -1.22M | $ 171.86K | $ -42.28K | $ -329.00K |
| Net Income | $ -1.27M | $ -1.13K | $ -52.72K | $ -340.00K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 34.74K | $ 17.00 | $ 1.32K | $ 12.34K |
| Total Assets | $ 72.72K | $ 17.00 | $ 1.32K | $ 12.34K |
| Total Debt | $ 189.59K | $ 0.00 | $ 142.20K | $ 140.70K |
| Net Debt | $ 154.85K | $ -17.00 | $ 140.88K | $ 128.36K |
| Total Liabilities | $ 762.30K | $ 1.17K | $ 222.19K | $ 195.44K |
| Stockholders' Equity | $ -689.58K | $ -1.15K | $ -220.87K | $ -183.10K |
| Cash Flow | ||||
| Free Cash Flow | $ -885.27K | $ 17.00 | $ -12.52K | $ -18.63K |
| Operating Cash Flow | $ -884.31K | $ 17.00 | $ -12.52K | $ -18.63K |
| Investing Cash Flow | $ -961.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 875.80K | $ 0.00 | $ 1.50K | $ 30.97K |
Currency in USD